Cargando...

Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.

Eleven children with bronchiolitis induced by respiratory syncytial virus received 10,000 to 70,000 U of recombinant interferon alpha-2a per kg of body weight per day. None developed signs of toxicity, and all but one developed an antiviral state following treatment. Interferon alpha-2a appears to b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Portnoy, J, Hicks, R, Pacheco, F, Olson, L
Formato: Artigo
Lenguaje:Inglês
Publicado: 1988
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC172227/
https://ncbi.nlm.nih.gov/pubmed/3377468
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!